Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03786939
NCT03786939
Recruiting
Not Applicable

Evaluation of Outcomes of Coronary Artery Bypass Grafting.

St. Petersburg State Pavlov Medical University1 site in 1 country1,000 target enrollmentDecember 20, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIschemic Heart DiseaseCoronary Artery Bypass Grafting

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Heart Disease
Sponsor
St. Petersburg State Pavlov Medical University
Enrollment
1000
Locations
1
Primary Endpoint
Death.
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Evaluation of outcomes of coronary artery bypass grafting.

Detailed Description

Evaluation of outcomes of coronary artery bypass grafting (CABG) on-, off- pump, pump assisted as well as bimammary coronary artery bypass grafting. Objective: To assess myocardial ischemic-reperfusion damage during different kinds of CABG. To assess complications after during different kinds of CABG.

Registry
clinicaltrials.gov
Start Date
December 20, 2018
End Date
December 20, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
St. Petersburg State Pavlov Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Ischemic heart disease with indications for coronary artery bypass grafting.

Exclusion Criteria

  • •valve disease

Outcomes

Primary Outcomes

Death.

Time Frame: 30 days during in stay.

Death during in-stay.

Secondary Outcomes

  • Death over 5 year after CABG.(within 5 years.)
  • Acute myocardial infarction after CABG.(within 5 years after CABG)
  • Death over 1 year after CABG.(1 year.)
  • Death over 3 year after CABG.(within 3 years.)
  • Shunt dysfunction during 30 days after CABG.(within 30 days after CABG)
  • Shunt dysfunction during 3 years after CABG.(within 3 years after CABG)
  • Shunt dysfunction during 5 years after CABG.(within 5 years after CABG)
  • Shunt dysfunction during 1 year after CABG.(within 1 year after CABG)
  • Stroke.(within 30 days after CABG)
  • Renal Dysfunction.(within 30 days after CABG)
  • Atrial fibrillation.(within 30 days after CABG)
  • IABP(within 30 days after CABG)
  • Residual myocardial ischemia.(within 30 days after CABG)
  • Infection or febrile.(within 30 days after CABG)

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Coronary artery bypass grafting in the evaluation of coronary artery volumeangina pectoris
JPRN-UMIN000045274Saitama Cardiovascular and Respiratory Center4
Completed
Not Applicable
Results of coronary artery bypass surgery in diabetic patientsCoronary artery bypass in diabetes type 2 patientsCirculatory System1. Coronary artery disease 2. Diabetes mellitus type 2
ISRCTN11781836Faculty of medicine and pharmacy of Rabat - Mohammed V university550
Recruiting
Not Applicable
Three-stages assessment of coronary artery bypass grafts patency by intraoperativetransit time flow measurementCoronary artery bypass grafting patencySurgery - Other surgeryCardiovascular - Coronary heart disease
ACTRN12619000137190Federal State Budgetary Scientific Institution Tomsk National Research Medical Center of the Russian Academy of Sciences”300
Not yet recruiting
Not Applicable
Effect of Coronary Artery Bypass Grafting (CABG) on oxygen delivery to Heart muscle.Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
CTRI/2019/01/017251Dr Harshil Joshi
Completed
Not Applicable
Follow-up of Coronary Artery Bypass Graft Patency by Multislice Computed TomographyCoronary Artery Disease
NCT00712153Far Eastern Memorial Hospital36